TJP1 and obesity disorder: Importantly, the ACM obtained from patients with obesity downregulated the expression levels of TJP1 and MUC2, suggesting a crosstalk between adipocytes and intestinal cells in which the pro-inflammatory profile of adipocytes may impair the integrity of intestinal barrier.